HOXA9 and CD163 potentiate pancreatic ductal adenocarcinoma progression

Abstract Background The role of HOXA9 requires investigations in pancreatic ductal adenocarcinoma (PDAC) as HOXA9 inhibitors are being developed. HOXA9 might attract CD163 expressed tumor associated macrophages (TAM) and could affect PDAC prognosis. This work aims to study the expression and relevan...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Egile Nagusiak: Aiat Shaban Hemida (Egilea), Mohamed Mohamady Ahmed (Egilea), Mona Saeed Tantawy (Egilea)
Formatua: Liburua
Argitaratua: BMC, 2024-10-01T00:00:00Z.
Gaiak:
Sarrera elektronikoa:Connect to this object online.
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Internet

Connect to this object online.

3rd Floor Main Library

Aleari buruzko argibideak 3rd Floor Main Library
Sailkapena: A1234.567
Alea 1 Eskuragarri